Christopher Migliaccio is a Research Associate Professor at the University of Montana. He earned his Ph.D. in Immunology at the University of California, Davis in 2000 and his Pharm.D. at the University of Montana in 2016. At the University of Montana, he received postdoctoral training in Molecular Virology under the guidance of Dr. Jack Nunberg at the Montana Biotechnology Center before moving to the Center for Environmental Health Sciences where he completed further postdoctoral training in Immunotoxicology under the guidance of Dr. Andrij Holian. He was promoted to Research Assistant Professor in Immunology in 2008. His research focuses on the effects of environmental exposures on respiratory immunity and function. Research in his laboratory has included health effects of exposures to nanomaterials, diesel exhaust particles, silica, and asbestos. Current work is focused on the health impacts in communities exposed to high levels of smoke from wildfires, including respiratory, cardiovascular, and behavioral/emotional outcomes following these events.

In addition to his research, Dr. Migliaccio is Core facility director and a clinical pharmacist. He has been the Director of the Inhalation and Pulmonary Physiology Core facility at UM since its inception. The Core facility is tasked with assisting researchers in design and implementing exposure studies. As the clinical pharmacist for the IPHARM program (ImProving Health Among Rural Montanans), Dr. Migliaccio trains clinical students and oversees the ambulatory care program. IPHARM travels throughout the state of Montana to provide health screenings and educations to rural communities. All these duties intersect with the wildfire smoke research and has enabled his group to continue to assess and educate those communities inundated with smoke from wildfire events.